Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Pressure-applying member, fixing device, and image forming apparatus
Flame-protected impact-modified polycarbonate compositions
Soft co-processors to provide a software service function off-load architecture in a multi-core processing environment
Systems and methods for simultaneously configuring multiple independent backups
Delivery of captions, content advisory and other data through digital interface
Reconfigurable barrel shifter and rotator
Immunotherapy in cancer treatment
  Randomly Featured Patents
Stamp pad with articulated hinge
Swimming pool modular construction
Eyeglasses with mid-temple hinge
Absorptive patient underpad
Method and device for adjusting the cooling and energy recovery of a steel strip in an annealing or galvanization phase
Turbine-impeller pump for use in geothermal energy recovery systems
Vehicle article carrier
Unified capture and process interface
Stent crimping system
Kitchen appliance having a container and having a cover configuration for closing the container